The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
ANTHOXANTHUM ODORATUM POLLEN, DACTYLIS GLOMERATA POLLEN, LOLIUM PERENNE POLLEN, PHLEUM PRATENSE POLLEN, and POA PRATENSIS POLLEN · POA PRATENSIS POLLEN 100 [IR]/1; DACTYLIS GLOMERATA POLLEN 100 [IR]/1; ANTHOXANTHUM ODORATUM POLLEN 100 [IR]/1; LOLIUM PERENNE POLLEN 100 [IR]/1; PHLEUM PRATENSE POLLEN 100 [IR]/1 · Tablet, Orally Disintegrating · Sublingual · Stallergenes
NDC 59617-0010-01 · 1 BLISTER PACK in 1 BOX / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · BLA · View full market →
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Cenexi Hsc | DACTYLIS GLOMERATA POLLEN 300 [IR]/1; ANTHOXANTHUM ODORATUM POLLEN 300 [IR]/1; LOLIUM PERENNE POLLEN 300 [IR]/1; PHLEUM PRATENSE POLLEN 300 [IR]/1; POA PRATENSIS POLLEN 300 [IR]/1 | Jul 22, 2026 | Sep 2, 2026 |
| Stallergenes | DACTYLIS GLOMERATA POLLEN 300 [IR]/1; ANTHOXANTHUM ODORATUM POLLEN 300 [IR]/1; LOLIUM PERENNE POLLEN 300 [IR]/1; PHLEUM PRATENSE POLLEN 300 [IR]/1; POA PRATENSIS POLLEN 300 [IR]/1 | Jul 22, 2026 | Sep 2, 2026 |
| Stallergenes | POA PRATENSIS POLLEN 100 [IR]/1; DACTYLIS GLOMERATA POLLEN 100 [IR]/1; ANTHOXANTHUM ODORATUM POLLEN 100 [IR]/1; LOLIUM PERENNE POLLEN 100 [IR]/1; PHLEUM PRATENSE POLLEN 100 [IR]/1 | Jul 22, 2026 | Sep 2, 2026 |
| Stallergenes | POA PRATENSIS POLLEN 300 [IR]/1; DACTYLIS GLOMERATA POLLEN 300 [IR]/1; ANTHOXANTHUM ODORATUM POLLEN 300 [IR]/1; LOLIUM PERENNE POLLEN 300 [IR]/1; PHLEUM PRATENSE POLLEN 300 [IR]/1 | Jul 22, 2026 | Sep 2, 2026 |
| Stallergenes | ANTHOXANTHUM ODORATUM POLLEN 300 [IR]/1; DACTYLIS GLOMERATA POLLEN 300 [IR]/1; LOLIUM PERENNE POLLEN 300 [IR]/1; PHLEUM PRATENSE POLLEN 300 [IR]/1; POA PRATENSIS POLLEN 300 [IR]/1 | Jul 15, 2026 | Jul 19, 2026 |
| Cenexi Hsc | ANTHOXANTHUM ODORATUM POLLEN 300 [IR]/1; DACTYLIS GLOMERATA POLLEN 300 [IR]/1; LOLIUM PERENNE POLLEN 300 [IR]/1; PHLEUM PRATENSE POLLEN 300 [IR]/1; POA PRATENSIS POLLEN 300 [IR]/1 | Jul 15, 2026 | Jul 15, 2026 |
| Stallergenes | ANTHOXANTHUM ODORATUM POLLEN 100 [IR]/1; DACTYLIS GLOMERATA POLLEN 100 [IR]/1; LOLIUM PERENNE POLLEN 100 [IR]/1; PHLEUM PRATENSE POLLEN 100 [IR]/1; POA PRATENSIS POLLEN 100 [IR]/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Oralair 100 IR — NDC 59617-0010-01," retrieved September 3, 2026, https://drugdashboards.com/drug/59617001001.
Free to cite with attribution — see how the data is put together.